Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 975 of 2529 entries
View as:

Study of Efficacy and Safety of Voretigene Neparvovec in Japanese Patients With Biallelic RPE65 Mutation-associated Retinal Dystrophy

Phase: N/A Priority: Normal
NCT ID: NCT04516369 Org: User:
Start: 11/24/20 End: 06/22/26 Due: 06/22/27

Nilotinib and LDE225 in the Treatment of Chronic or Accelerated Phase Myeloid Leukemia in Patients Who Developed Resistance to Prior Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01456676 Org: User:
Start: 01/31/12 End: 02/28/14 Due: 02/28/15

Exacerbation Study

Phase: N/A Priority: Normal
NCT ID: NCT00845728 Org: User:
Start: 03/31/09 End: 07/31/12 Due: 07/31/13

Phase II Study Evaluating the Efficacy and Safety of Ociperlimab in Combination With Tislelizumab and Chemotherapy as First-line Treatment for Participants With Advanced Triple Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05809895 Org: User:
Start: 09/15/23 End: 07/18/29 Due: 07/18/30

Multiple-loading Dose Regimen Study in Patients With Chronic Plaque-type Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00805480 Org: User:
Start: 12/31/08 End: 09/30/10 Due: 09/30/11

Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT06597019 Org: User:
Start: 12/09/24 End: 04/15/29 Due: 04/15/30

Study to Allow Access to Single Agent Panobinostat for Patients Who Are on s.a. Panobinostat Treatment in a Novartis-sponsored Study and Continue to Benefit From the Treatment as Judged by the Investigator

Phase: N/A Priority: Normal
NCT ID: NCT01802879 Org: User:
Start: 06/24/13 End: 11/19/18 Due: 11/19/19

Trial of Telbivudine Combination Therapy vs. Continued Adefovir Monotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00409019 Org: User:
Start: - End: - Due: -

LDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01685138 Org: User:
Start: 12/20/12 End: 01/22/18 Due: 01/22/19

Treatment of Locally Advanced Breast Cancer With Letrozole in Postmenopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT00237133 Org: User:
Start: 03/31/03 End: 01/21/09 Due: 01/21/10

Phase I/II Study of [225Ac]Ac-PSMA-R2 in PSMA-positive Prostate Cancer, With/Without Prior 177Lu-PSMA RLT

Phase: N/A Priority: Normal
NCT ID: NCT05983198 Org: User:
Start: 11/07/23 End: 11/05/29 Due: 11/05/30

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

Phase: N/A Priority: Normal
NCT ID: NCT05939414 Org: User:
Start: 03/12/24 End: 07/09/30 Due: 07/09/31

A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids

Phase: N/A Priority: Normal
NCT ID: NCT05653219 Org: User:
Start: 02/02/23 End: 04/10/28 Due: 04/10/29

Dose Escalation Study of AUY922 in Advanced Solid Malignancies in Japan

Phase: N/A Priority: Normal
NCT ID: NCT01132625 Org: User:
Start: 11/30/08 End: 05/31/12 Due: 05/31/13

Characteristics of Patients With Neovascular Age-related Macular Degeneration Enrolled in the Brolucizumab Patient Support Services Program

Phase: N/A Priority: Normal
NCT ID: NCT05066685 Org: User:
Start: 08/11/20 End: 09/25/20 Due: 09/25/21

Efficacy, Safety, and Pharmacokinetics of QAW039

Phase: N/A Priority: Normal
NCT ID: NCT01253603 Org: User:
Start: 11/30/10 End: 09/30/11 Due: 09/30/12

Intensified vs. Standard Dose Therapy With Mycophenolate Sodium Plus Cyclosporin Microemulsion and Corticosteroid Combination in Patients With de Novo Renal Transplant Patients

Phase: N/A Priority: Normal
NCT ID: NCT00369278 Org: User:
Start: 06/30/06 End: 12/31/08 Due: 12/31/09

Study of Dabrafenib+Trametinib in the Adjuvant Treatment of Stage III BRAF V600+ Melanoma After Complete Resection to Evaluate the Impact on Pyrexia Related Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT03551626 Org: User:
Start: 08/29/18 End: 09/16/21 Due: 09/16/22

SCHEDULE Follow Up Visit 5-7 yr

Phase: N/A Priority: Normal
NCT ID: NCT02864706 Org: User:
Start: 01/18/16 End: 09/25/17 Due: 09/25/18

LDK378 in Adult Patients With ALK-activated NSCLC Previously Treated With Chemotherapy and Crizotinib

Phase: N/A Priority: Normal
NCT ID: NCT01685060 Org: User:
Start: 11/26/12 End: 03/29/16 Due: 03/29/17

Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease Participants

Phase: N/A Priority: Normal
NCT ID: NCT05469360 Org: User:
Start: 02/23/23 End: 11/07/27 Due: 11/07/28

Special Drug Use-results Surveillance of Scemblix Tablets

Phase: N/A Priority: Normal
NCT ID: NCT05421091 Org: User:
Start: 07/04/22 End: 02/29/24 Due: 02/28/25

Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT04382053 Org: User:
Start: 05/27/20 End: 12/24/20 Due: 12/24/21

Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00237198 Org: User:
Start: 03/31/04 End: - Due: -

Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients

Phase: N/A Priority: Normal
NCT ID: NCT01922089 Org: User:
Start: 11/30/13 End: 08/31/14 Due: 08/31/15